ES2065434T3 - Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos. - Google Patents
Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos.Info
- Publication number
- ES2065434T3 ES2065434T3 ES90111717T ES90111717T ES2065434T3 ES 2065434 T3 ES2065434 T3 ES 2065434T3 ES 90111717 T ES90111717 T ES 90111717T ES 90111717 T ES90111717 T ES 90111717T ES 2065434 T3 ES2065434 T3 ES 2065434T3
- Authority
- ES
- Spain
- Prior art keywords
- aerosols containing
- containing cytokines
- properly
- cytokine
- oncoses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
YA SON CONOCIDAS DIFERENTES APLICACIONES DE CITOKIN PARA EL TRATAMIENTO DE TUMORES. SIN EMBARGO, PRESENTAN CIERTOS INCONVENIENTES. MEDIANTE LA APLICACION DE AEROSOLES CON CONTENIDO DE CITOKIN PARA LA APLICACION INHALATIVA E INMUNOACTIVA, CONCRETAMENTE REGULACION INMUNOLOGICA Y CONTINUADA EN CASO DE ENFERMEDADES REFERIDAS A TUMORES, SE CONSIGUE REDUCIR LOS INCONVENIENTES HASTA AHORA CONOCIDOS. ADEMAS LA INVENCION NOS MUESTRA SUSTANCIAS CON CONTENIDO DE CITOKIN PARA LA ELABORACION DE UNA PREPARACION DE UN MEDICAMENTO CON AEROSOL PARA UNA APLICACION INHALATIVA E INMUNOACTIVA, CONCRETAMENTE PARA LA APLICACION EN ENFERMEDADES DE TUMORES, DE UNA REGULACION INMUNOLOGICA Y CONTINUADA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90111717A EP0462305B1 (de) | 1990-06-21 | 1990-06-21 | Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2065434T3 true ES2065434T3 (es) | 1995-02-16 |
Family
ID=8204117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90111717T Expired - Lifetime ES2065434T3 (es) | 1990-06-21 | 1990-06-21 | Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5399341A (es) |
EP (1) | EP0462305B1 (es) |
JP (1) | JPH04230222A (es) |
AT (1) | ATE113469T1 (es) |
CA (1) | CA2043992A1 (es) |
DE (1) | DE59007645D1 (es) |
DK (1) | DK0462305T3 (es) |
ES (1) | ES2065434T3 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0986393B1 (en) * | 1997-05-27 | 2004-03-24 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
CZ20022265A3 (cs) * | 1999-12-30 | 2004-01-14 | Chiron Corporation | Léčivo pro podávání interleukinu-2 a stabilizovaný lyofilizovaný nebo sprejově sušený farmaceutický prostředek s obsahem interleukinu-2 |
US20030072717A1 (en) * | 2001-02-23 | 2003-04-17 | Vapotronics, Inc. | Inhalation device having an optimized air flow path |
DK1389137T3 (da) * | 2001-05-21 | 2006-10-30 | Injet Digital Aerosols Ltd | Sammensætninger til lungelægemiddellevering af protein |
US20120288474A1 (en) * | 2009-11-06 | 2012-11-15 | Protaffin Biotechnologie Ag | Composition for treatment of cxcl8-mediated lung inflammation |
PT2528617E (pt) | 2010-01-28 | 2016-03-31 | Immunservice Gmbh | Interleucina-2 ou interferão-alfa para uso no tratamento da dependência de nicotina ou de alimentos |
CN102462837B (zh) * | 2010-11-19 | 2016-08-03 | 生物林格斯Ip有限公司 | 抗炎组合物 |
WO2013075719A1 (en) | 2011-11-23 | 2013-05-30 | Flsmidth A/S | Method and plant for manufacturing cement clinker |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
JPS60224616A (ja) * | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
JPS6160620A (ja) * | 1984-09-03 | 1986-03-28 | Teijin Ltd | ピログルタミン酸エステル類を含有する医薬品組成物 |
JPS61194034A (ja) * | 1985-02-25 | 1986-08-28 | Teijin Ltd | 経鼻投与用粉末状組成物 |
JPS62207226A (ja) * | 1986-03-07 | 1987-09-11 | Sumitomo Pharmaceut Co Ltd | 経鼻投与用製剤 |
US4832686A (en) * | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
EP0257956B2 (en) * | 1986-08-19 | 2000-11-22 | Genentech, Inc. | Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
US5162507A (en) * | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
JPH02124832A (ja) * | 1988-07-08 | 1990-05-14 | Toray Ind Inc | インターヘェロンβ組成物 |
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
US5011678A (en) * | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
-
1990
- 1990-06-21 EP EP90111717A patent/EP0462305B1/de not_active Expired - Lifetime
- 1990-06-21 DE DE59007645T patent/DE59007645D1/de not_active Expired - Lifetime
- 1990-06-21 AT AT90111717T patent/ATE113469T1/de not_active IP Right Cessation
- 1990-06-21 ES ES90111717T patent/ES2065434T3/es not_active Expired - Lifetime
- 1990-06-21 DK DK90111717.6T patent/DK0462305T3/da active
-
1991
- 1991-06-06 CA CA002043992A patent/CA2043992A1/en not_active Abandoned
- 1991-06-19 US US07/717,824 patent/US5399341A/en not_active Expired - Lifetime
- 1991-06-21 JP JP91149026A patent/JPH04230222A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5399341A (en) | 1995-03-21 |
ATE113469T1 (de) | 1994-11-15 |
DK0462305T3 (da) | 1995-04-24 |
JPH04230222A (ja) | 1992-08-19 |
DE59007645D1 (de) | 1994-12-08 |
EP0462305B1 (de) | 1994-11-02 |
EP0462305A1 (de) | 1991-12-27 |
CA2043992A1 (en) | 1991-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL101145A0 (en) | Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives | |
ES2128411T3 (es) | Inhalador de polvo con soportes de polvo con microestructuras regulares. | |
FI862011A (fi) | Terapeutiska nukleosider. | |
IL87621A0 (en) | Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them | |
MX9200361A (es) | Nuevo uso del antagonista de adenosina. | |
DK203787A (da) | Praeparat til nasal administrering | |
DK0392300T3 (da) | Anvendelse af lægemidler, der indeholder mindst et cytokin, til systemisk behandling af præneoplastiske læsioner | |
DE69003923D1 (de) | Inhalator und Schutzbehälter. | |
DK0500773T3 (da) | Ikke-glycosyleret FGF-4 og præparater indeholdende dette | |
ATE26216T1 (de) | Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung. | |
ES2065434T3 (es) | Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos. | |
DK0551077T3 (da) | Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb | |
IT1240683B (it) | Composizione farmaceutica contenente egf | |
DK0764023T3 (da) | Forbindelser og præparater til administrering via oral inhalation eller insufflation | |
MX9203615A (es) | Composicion farmaceutica en forma de polvo para administracion nasal. | |
ATE189262T1 (de) | Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen | |
IL89816A (en) | Synergistically active veterinary compositions containing polymyxin b and chlorquinaldol, their preparation and use | |
DE59203456D1 (de) | Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung. | |
MY110074A (en) | Pharmacuetical formulation. | |
IT8722647A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
EP0536311A4 (en) | Compositions comprising vitamin d precursors, analogs thereof and their use | |
DE69208913D1 (de) | 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung | |
DE69206460D1 (de) | Injizierbare 2-Oxindol-1-carboxamidderivate enthaltende Arzneizubereitungen. | |
MX9102702A (es) | Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas. | |
IT230397Y1 (it) | Struttura di inalatore per uso medicale,particolarmente per bambini |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 462305 Country of ref document: ES |